BACKGROUND: Helicobacter pylori-cytotoxin-associated protein A (CagA) and gastrin are believed to play an important role in gastric carcinogenesis, but their interaction has been incompletely clear. METHODS: We constructed a eukaryotic expression vector pcDNA3.1/cagA and a luciferase reporter vector pGL/gastrin promoter, and then co-transfected them into gastric cancer AGS and SGC-7901 cells. The two kinds of gastric cancer cells were, respectively, infected with cagA-positive H. pylori NCTC11637, and then the gastrin promoter activity and gastrin mRNA level were detected with a Dual-Luciferase reporter assay system and quantitative reverse transcription polymerase chain reaction (RT-PCR), respectively. Next, after the MEK/ERK and JAK2-signaling pathway inhibitors, U0126 and AG490, were used to treat the two cell lines, or the ERK1 and JAK2 genes were knocked down by siRNAs (small interference RNAs) in the two cell lines, the gastrin promoter activity and gastrin mRNA level were observed again. RESULTS: The results indicated that CagA could activate the gastrin promoter and up-regulate gastrin mRNA expression in AGS and SGC-7901 cells, but these effects could be inhibited by the inhibitors U0126 and AG490, and the CagA-induced gastrin mRNA expression was down-regulated in the cells whose ERK1 or JAK2 gene was knocked down. CONCLUSION: Gastrin promoter may be the transcriptional target of CagA, and CagA activates the gastrin promoter to up-regulate gastrin mRNA expression through the MEK/ERK and JAK1-signaling pathway in gastric cancer cells.
BACKGROUND:Helicobacter pylori-cytotoxin-associated protein A (CagA) and gastrin are believed to play an important role in gastric carcinogenesis, but their interaction has been incompletely clear. METHODS: We constructed a eukaryotic expression vector pcDNA3.1/cagA and a luciferase reporter vector pGL/gastrin promoter, and then co-transfected them into gastric cancerAGS and SGC-7901 cells. The two kinds of gastric cancer cells were, respectively, infected with cagA-positive H. pylori NCTC11637, and then the gastrin promoter activity and gastrin mRNA level were detected with a Dual-Luciferase reporter assay system and quantitative reverse transcription polymerase chain reaction (RT-PCR), respectively. Next, after the MEK/ERK and JAK2-signaling pathway inhibitors, U0126 and AG490, were used to treat the two cell lines, or the ERK1 and JAK2 genes were knocked down by siRNAs (small interference RNAs) in the two cell lines, the gastrin promoter activity and gastrin mRNA level were observed again. RESULTS: The results indicated that CagA could activate the gastrin promoter and up-regulate gastrin mRNA expression in AGS and SGC-7901 cells, but these effects could be inhibited by the inhibitors U0126 and AG490, and the CagA-induced gastrin mRNA expression was down-regulated in the cells whose ERK1 or JAK2 gene was knocked down. CONCLUSION:Gastrin promoter may be the transcriptional target of CagA, and CagA activates the gastrin promoter to up-regulate gastrin mRNA expression through the MEK/ERK and JAK1-signaling pathway in gastric cancer cells.
Authors: P C Konturek; A Hartwich; M Zuchowicz; H Labza; P Pierzchalski; E Karczewska; W Bielanski; E G Hahn; S J Konturek Journal: J Physiol Pharmacol Date: 2000-12 Impact factor: 3.011
Authors: S J Konturek; T Starzynska; P C Konturek; E Karczewska; K Marlicz; M Lawniczak; H Jaroszewicz-Heigelman; W Bielanski; A Hartwich; A Ziemniak; E G Hahn Journal: Scand J Gastroenterol Date: 2002-08 Impact factor: 2.423
Authors: Michael R Stephens; Andrew N Hopper; Wyn G Lewis; Guy Blackshaw; Paul Edwards; Becky Osborne; Ian W Thompson Journal: Gastric Cancer Date: 2007-09-26 Impact factor: 7.370
Authors: Shigeo Takaishi; Shuiping Tu; Zinaida A Dubeykovskaya; Mark T Whary; Sureshkumar Muthupalani; Barry H Rickman; Arlin B Rogers; Nantaporn Lertkowit; Andrea Varro; James G Fox; Timothy C Wang Journal: Am J Pathol Date: 2009-07 Impact factor: 4.307